Background SARS-CoV-2 vaccines are highly effective at preventing COVID-19-related
morbidity and mortality. As no vaccine is 100% effective, breakthrough infections are expected to …

Background Performance of the SD Biosensor saliva antigen rapid test was evaluated at a
large designated testing site in non-hospitalized patients, with or without symptoms. Method …

Here, we describe the clinical phenotype of SARS-CoV-2-related CNS disease and evaluate
the SARS-CoV-2 antibody index as a tool to differentiate between a direct (viral) and …

Rabies virus (RABV) has a broad host range and infects multiple cell types throughout the
infection cycle. Next-generation sequencing (NGS) and minor variant analysis are powerful …

… Bibi Slingerland, Ga-Lai Chong, Rose Willemze, Jordy Dekker, George Sips, Stephanie
Popping, Daphne Mulders, Alex de Ries, and Jeroen Ijpelaar gratefully acknowledged for their …

… Ga-Lai Chong, Rose Willemze, Jordy Dekker, George Sips, Stephanie Popping, Daphne
Mulders, Alex de Ries and Jeroen Ijpelaar gratefully acknowledged for their technical and …

Assays to measure SARS-CoV-2-specific neutralizing antibodies are important to monitor
seroprevalence, to study asymptomatic infections and to reveal (intermediate) hosts. A recently …

A middle-aged man presented with imbalance and involuntary jerky movements of the body
3 weeks after initial recovery from coronavirus disease 2019 (COVID-19) lung infection, …

Background Although preventable by vaccination for more than a century, rabies virus still
causes numerous fatalities every year. To determine antibody levels in humans, blood …

Background and Objectives Autoimmune encephalitis (AE) cases after severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection have been reported, but the frequency …